Who invested in Epicrispr Biotechnologies

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 3 months ago

Funding summaryUpdated 26 Oct 2026

$90Mraised across 1 round since 2026, from 1 source

Latest round: Series C, $90MAug 2026
Investors: 4

See who backed them

The rounds

Aug 2026
Series C$90M
Source recordedSEC filing: $177M sold

Founders and team

From Epicrispr Biotechnologies's own website: 24 on the team.

Abhi GopalakrishnanHead of Quality
Aayushma GautamAssociate Scientist
Abhinav AdhikariPrincipal Scientist
Courtney KlappenbachAssociate Scientist
Danny KoSenior Scientist
Emerson SosaClinical Trial Manager
Hao ZhangSenior Research Associate
Hardeep SinghPrincipal Scientist
Jackson PowellAssociate Scientist
Jimmy LiangAssociate Director, Operations
Kaitlin PensabeneAssociate Scientist
Kavita Jadhav-WhalenClinical Research Scientist
Kirsty JamiesonSenior Scientist
Linsin SmithSenior Scientist
Melanie SilvisPrincipal Scientist
Nalinda WasalaDirector of Therapeutics
Nina Juan-SingAssociate Scientist
Paul HolzapfelSenior Manager, Clinical Quality Assurance

And 6 more on the team.

Everyone who backed them

FidelityVC firm1round

Janus Henderson InvestorsPrivate equity1round

Cormorant Asset ManagementPrivate equity1round

SanofiInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Epicrispr Biotechnologies

Who invested in Epicrispr Biotechnologies?

Epicrispr Biotechnologies's investors include Fidelity, Janus Henderson Investors, Cormorant Asset Management and Sanofi.

How much has Epicrispr Biotechnologies raised?

Epicrispr Biotechnologies has raised $90M across 1 round since 2026.

When did Epicrispr Biotechnologies last raise?

Epicrispr Biotechnologies's most recent round was a Series C of $90M in Aug 2026.

What was Epicrispr Biotechnologies's biggest round?

Its most recent round, $90M in Aug 2026, is also its largest on record.

Who backed Epicrispr Biotechnologies first?

Epicrispr Biotechnologies's first round on record, in Aug 2026, was backed by Fidelity, Janus Henderson Investors and Cormorant Asset Management and 1 others.